The University of Maryland School of Medicine uses OpenClinica's EDC platform to support their multi-center aneurysm trial.
OpenClinica, LLC announces that University of Maryland School of Medicine has selected the OpenClinica Enterprise Edition for the Ultra Registry, a multi-center aneurysm trial led by Dr. Gaurav Jindal, Professor of Diagnostic Radiology. The radiology department at the University of Maryland has state-of-the-art facilities and cutting-edge technologies, making it one of the most sophisticated in the world. The development and integration of nuclear medicine, ultrasonography, computed tomography and magnetic resonance imaging (MRI) has provided diagnostic imaging with an even more central role in diagnosis and selected (interventional) therapeutic procedures.
Gabrielle Messina, data manager and clinical research specialist for the Ultra Registry, chose OpenClinica based on the open architecture and the ability to receive professional training, not only on the OpenClinica system but on best practices in executing a clinical trial with an EDC system. “I took OpenClinica’s training in February of this year and the staff was committed to ensuring my success. I needed extra guidance, specific to my study, and the knowledgeable client services team took the time, outside of class, to make sure I understood how to build and validate my CRFs. The commitment and professionalism of the OpenClinica team was outstanding and confirmed not only the great value of this EDC system, but has given me peace of mind with my capacity to execute my trial,” said Gabrielle.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.